A vaccine design approach that could protect against new variants of SARS-CoV-2 (the virus that causes COVID-19) but also potentially protects against other coronaviruses is one step closer to reality as a result of Penn ...
Oct 18, 2022
0
170
An entirely new approach to monoclonal antibody therapy shows that targeting the more genetically stable internal protein of the SARS-CoV-2 virus rather than the surface spike protein can also clear SARS-CoV-2, reports a ...
Oct 14, 2022
0
60
University of Maryland School of Medicine researchers have identified how multiple genes of SARS-CoV-2 affect disease severity, which could lead to new ways in how we develop future vaccines or develop newer treatments. The ...
Oct 7, 2022
1
54
Scientists at Scripps Research, IAVI, the Ragon Institute and Moderna, Inc., have come together to make critical advances in developing an effective vaccine against human immunodeficiency virus (HIV).
Oct 3, 2022
0
56
A Brazilian study published in the journal PNAS describes some of the effects infection by SARS-CoV-2 can have on the central nervous system. A preliminary version (not yet peer-reviewed) posted in 2020 was one of the first ...
Oct 1, 2022
0
670
Vaccines (predominantly mRNA vaccines) have been our front-line defense against COVID and have saved millions of lives.
Sep 26, 2022
0
16
A recently discovered virus in a Russian bat that is similar to SARS-CoV-2, the virus behind COVID-19, is likely capable of infecting humans and, if it were to spillover, is resistant to current vaccines.
Sep 22, 2022
0
130
The Centers for Disease Control and Prevention (CDC) recently released new recommendations for COVID-19 booster vaccinations. The shots, called bivalent vaccines, are designed to protect people from the original coronavirus ...
Sep 19, 2022
0
9
University of Alberta research shows how cell membranes play a much larger role than previously understood in allowing spike proteins on viruses to infect cells. The findings, published in the journal iScience, could give ...
Sep 16, 2022
0
74
A large team of researchers at the University of Texas Medical Branch, working with two colleagues from the University of Pennsylvania Perelman School of Medicine and two with the Mayo Clinic, has developed a vaccine for ...
